Form 4: Xometry Director Sells Shares Under 10b5-1 Plan
Statement of Changes in Beneficial Ownership
Xometry Director Emily Rollins reported the sale of 1,000 shares of Class A Common Stock under a pre-arranged trading plan.
Summary
- Director Emily Rollins sold 1,000 shares of Xometry, Inc. Class A Common Stock on April 1, 2026.
- The transaction was executed as part of a Rule 10b5-1 trading plan, adopted at least 90 days prior to the trade date.
- The shares were sold at a weighted average price of $42.0174, with individual sale prices ranging from $41.60 to $42.42.
- Following the sale, Rollins beneficially owns 15,136 shares of Class A Common Stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While it involves a director selling shares, the transaction was conducted under a pre-arranged Rule 10b5-1 plan, mitigating concerns about opportunistic selling.
Positives
- The sale was conducted under a Rule 10b5-1 plan, indicating pre-planned and potentially less market-sensitive trading activity.
- The reporting person retains a significant number of shares (15,136) after the transaction.
Negatives
- A director has sold a portion of their holdings, which could be perceived negatively by the market, although it was pre-planned.
Risks
- The filing does not explicitly mention any new or evolving risks. The primary risk is the potential market perception of insider selling, even if executed under a 10b5-1 plan.
Future Outlook
The filing does not contain forward-looking statements or guidance. It solely reports a past transaction.
Industry Context
StockSavvy.ai notes that insider selling, particularly under Rule 10b5-1 plans, is a common occurrence for executives and directors. These plans are designed to allow insiders to sell shares without violating insider trading rules, but they can still influence market sentiment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Rule 10b5-1 Trading Plan | Transaction executed under a pre-arranged Rule 10b5-1 trading plan for the sale of equity securities. | At least 90 days prior to 04/01/2026 | Demonstrates adherence to corporate governance best practices for insider trading compliance. |
Stakeholder Impact
- Shareholders: May observe the transaction, but the Rule 10b5-1 plan suggests it's not indicative of a negative view of the company's future prospects.
- Management: Reinforces the importance of compliance with SEC regulations regarding beneficial ownership reporting.
Next Steps
- The reporting person will continue to hold the remaining 15,136 shares of Class A Common Stock.
- The stock option reported is fully vested and can be exercised.
Key Dates
| Date | Description |
|---|---|
| 04/01/2026 | Transaction Date for sale of Class A Common Stock and exercise of stock option. |
| 02/24/2031 | Expiration date of the stock option. |
| 04/03/2026 | Date of signature for the filing. |
Keywords
Xometry, XMTR, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Director Transaction, Class A Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.